3 |
1 |
Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups |
Pajtler KW, Pfister SM |
Cancer Cell |
2015 |
321 |
53.5 |
Germany |
Basic science |
5 |
2 |
C11orf95-RELA fusions drive oncogenic Nf-kappa B signalling in ependymoma |
Parker M, Gilbertson RJ |
Nature |
2014 |
272 |
38.86 |
USA |
Basic science |
1 |
3 |
Radial glia cells are candidate stem cells of ependymoma |
Taylor MD, Gilbertson RJ |
Cancer Cell |
2005 |
551 |
34.44 |
USA |
Basic science |
7 |
4 |
Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma |
Witt H, Pfister SM |
Cancer Cell |
2011 |
244 |
24.4 |
Germany |
Basic science |
50 |
5 |
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants |
Pajtler KW, Taylor MD |
Acta Neuropathologica |
2017 |
89 |
22.25 |
Germany |
Review |
6 |
6 |
Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study |
Merchant TE, Sanford RA |
Lancet Oncology |
2009 |
258 |
21.5 |
USA |
Clinical |
9 |
7 |
Cross-species genomics matches driver mutations and cell compartments to model ependymoma |
Johnson RA, Gilbertson RJ |
Nature |
2010 |
219 |
19.91 |
USA |
Basic science |
2 |
8 |
Intramedullary ependymoma of the spinal cord |
Mccormick PC, Stein BM |
Journal of Neurosurgery |
1990 |
453 |
14.61 |
USA |
Clinical |
82 |
9 |
Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma |
Peeler CR, Grosshans DR |
Radiotherapy and Oncology |
2016 |
65 |
13 |
USA |
Clinical |
83 |
10 |
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis |
Ramaswamy V, Taylor MD |
Journal of Clinical Oncology |
2016 |
65 |
13 |
Canada |
Clinical |
30 |
11 |
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts |
Ellison DW, Grundy RG |
Journal of Negative Results in Biomedicine |
2011 |
123 |
12.3 |
USA |
Clinical |
11 |
12 |
Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma |
Merchant TE, Sanford RA |
Journal of Clinical Oncology |
2004 |
201 |
11.82 |
USA |
Clinical |
35 |
13 |
Molecular staging of intracranial ependymoma in children and adults |
Korshunov A, Pfister SM |
Journal of Clinical Oncology |
2010 |
119 |
10.82 |
Germany |
Basic science |
14 |
14 |
Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics |
Modena P, Sozzi G |
Journal of Clinical Oncology |
2006 |
160 |
10.67 |
Italy |
Basic science |
15 |
15 |
Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma |
Mendrzyk F, Lichter P |
Clinical Cancer Research |
2006 |
156 |
10.4 |
Germany |
Basic science |
23 |
16 |
Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study |
Grundy RG, Machin D |
Lancet Oncology |
2007 |
139 |
9.93 |
UK |
Clinical |
27 |
17 |
Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons |
Macdonald SM, Yock T |
International Journal of Radiation Oncology Biology Physics |
2008 |
126 |
9.69 |
USA |
Clinical |
69 |
18 |
Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients |
Macdonald SM, Yock TI |
Neuro-Oncology |
2013 |
76 |
9.5 |
USA |
Clinical |
38 |
19 |
Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study clinical article |
Mcguire CS, Fisher PG |
Journal of Neurosurgery |
2009 |
112 |
9.33 |
USA |
Clinical |
63 |
20 |
A prognostic gene expression signature in infratentorial ependymoma |
Wani K, Aldape K |
Acta Neuropathologica |
2012 |
78 |
8.67 |
USA |
Basic science |
13 |
21 |
Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French society of pediatric oncology |
Grill J, Kalifa C |
Journal of Clinical Oncology |
2001 |
173 |
8.65 |
France |
Clinical |
42 |
22 |
Pediatric ependymoma: biological perspectives |
Kilday JP, Grundy R |
Molecular Cancer Research |
2009 |
101 |
8.42 |
UK |
Review |
100 |
23 |
Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma |
Broniscer A, Ellison DW |
Neuropathology and Applied Neurobiology |
2014 |
58 |
8.29 |
USA |
Clinical |
57 |
24 |
Identification of microRNAs as potential prognostic markers in ependymoma |
Costa FF Soares MB |
Plos One |
2011 |
80 |
8 |
USA |
Basic science |
10 |
25 |
Natural simian-virus-40 strains are present in human choroid-plexus and ependymoma tumors |
Lednicky JA, Butel JS |
Virology |
1995 |
206 |
7.92 |
USA |
Basic science |
32 |
26 |
Monomorphous angiocentric glioma: a distinctive epileptogenic neoplasm with features of infiltrating astrocytoma and ependymoma |
Wang M, Burger PC |
Journal of Neuropathology and Experimental Neurology |
2005 |
121 |
7.56 |
USA |
Clinical |
46 |
27 |
A retrospective study of surgery and reirradiation for recurrent ependymoma |
Merchant TE, Sanford RA |
International Journal of Radiation Oncology Biology Physics |
2008 |
96 |
7.38 |
USA |
Clinical |
74 |
28 |
An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma |
Atkinson JM, Gilbertson RJ |
Cancer Cell |
2011 |
71 |
7.1 |
USA |
Basic science |
16 |
29 |
Molecular genetic analysis of ependymal tumors: Nf2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas |
Ebert C, Von Deimling A |
American Journal of Pathology |
1999 |
154 |
7 |
USA |
Basic science |
88 |
30 |
Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation |
Bouffet E, Tabori U |
International Journal of Radiation Oncology Biology Physics |
2012 |
62 |
6.89 |
Canada |
Clinical |
55 |
31 |
Both location and age predict survival in ependymoma: a seer study |
Mcguire CS, Fisher PG |
Pediatric Blood & Cancer |
2009 |
81 |
6.75 |
USA |
Clinical |
26 |
32 |
Spinal cord ependymoma: radical surgical resection and outcome |
Hanbali F, Gokaslan ZL |
Neurosurgery |
2002 |
127 |
6.68 |
USA |
Clinical |
4 |
33 |
Ependymoma: follow-up-study of 101 cases |
Mork SJ, Loken AC |
Cancer |
1977 |
290 |
6.59 |
Norway |
Clinical |
18 |
34 |
Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma |
Chan AS, Chung LP |
American Journal of Surgical Pathology |
1998 |
151 |
6.57 |
Hong Kong |
Basic science |
31 |
35 |
Erbb receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease |
Gilbertson RJ Ellison DW |
Clinical Cancer Research |
2002 |
123 |
6.47 |
USA |
Basic science |
49 |
36 |
Ependymoma |
Reni M, Vecht C |
Critical Reviews in Oncology Hematology |
2007 |
90 |
6.43 |
Italy |
Review |
54 |
37 |
Predicting change in academic abilities after conformal radiation therapy for localized ependymoma |
Conklin HM, Merchant TE |
Journal of Clinical Oncology |
2008 |
83 |
6.38 |
USA |
Clinical |
8 |
38 |
Myxopapillary ependymoma: a clinicopathologic and immunocytochemical study of 77 cases |
Sonneland PR, Onofrio BM |
Cancer |
1985 |
226 |
6.28 |
USA |
Clinical |
58 |
39 |
Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective |
De Bont JM, Pieters R |
Neuro-Oncology |
2008 |
80 |
6.15 |
Netherlands |
Review |
12 |
40 |
The prognostic-significance of postoperative residual tumor in ependymoma |
Healey EA, Tarbell NJ |
Neurosurgery |
1991 |
184 |
6.13 |
USA |
Clinical |
21 |
41 |
Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group |
Perilongo G, Madon E |
Medical and Pediatric Oncology |
1997 |
144 |
6 |
Italy |
Clinical |
64 |
42 |
Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma |
Ridley L, Grundy RG |
Neuro-Oncology |
2008 |
78 |
6 |
UK |
Clinical |
84 |
43 |
Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial |
Grundy RG, Machin D |
European Journal of Cancer |
2010 |
65 |
5.91 |
UK |
Clinical |
17 |
44 |
Treatment of intracranial ependymomas of children: review of a 15-year experience |
Rousseau P, Rey A |
International Journal of Radiation Oncology Biology Physics |
1994 |
154 |
5.7 |
France |
Clinical |
36 |
45 |
Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials hit 88/89 and hit 91 |
Timmermann B Bamberg M |
International Journal of Radiation Oncology Biology Physics |
2000 |
118 |
5.62 |
Germany |
Clinical |
33 |
46 |
A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors |
Horn B, Russo C |
Journal of Pediatric Hematology Oncology |
1999 |
121 |
5.5 |
USA |
Clinical |
28 |
47 |
Ependymoma: results, prognostic factors and treatment recommendations |
Mclaughlin MP, Million RR |
International Journal of Radiation Oncology Biology Physics |
1998 |
126 |
5.48 |
USA |
Clinical |
59 |
48 |
Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at MD Anderson Cancer Center |
Akyurek S, Woo SY |
Journal of Neuro-Oncology |
2006 |
80 |
5.33 |
USA |
Clinical |
78 |
49 |
Differential expression and prognostic significance of sox genes in pediatric medulloblastoma and ependymoma identified by microarray analysis |
De Bont JM, Pieters R |
Neuro-Oncology |
2008 |
69 |
5.31 |
Netherlands |
Basic science |
70 |
50 |
Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma |
Tabori U, Hawkins C |
Journal of Clinical Oncology |
2006 |
76 |
5.07 |
Canada |
Clinical |
44 |
51 |
Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups |
Hirose Y, Feuerstein BG |
American Journal of Pathology |
2001 |
98 |
4.9 |
USA |
Basic science |
65 |
52 |
Radiation dosimetry predicts iq after conformal radiation therapy in pediatric patients with localized ependymoma |
Merchant TE, Mulhern RK |
International Journal of Radiation Oncology Biology Physics |
2005 |
78 |
4.88 |
USA |
Clinical |
66 |
53 |
Ependymoma: new therapeutic approaches including radiation and chemotherapy |
Merchant TE, Fouladi M |
Journal of Neuro-Oncology |
2005 |
78 |
4.88 |
USA |
Clinical |
80 |
54 |
Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival |
Lukashova-Von Zangen I, Roggendorf W |
Acta Neuropathologica |
2007 |
66 |
4.71 |
Germany |
Basic science |
95 |
55 |
Central nervous system tumors with ependymal features: a broadened spectrum of primarily ependymal differentiation? |
Lehman NL |
Journal of Neuropathology And Experimental Neurology |
2008 |
59 |
4.54 |
USA |
Review |
89 |
56 |
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue |
Zacharoulis S, Finlay J |
Pediatric Blood & Cancer |
2007 |
62 |
4.43 |
USA |
Clinical |
25 |
57 |
Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy |
Vanuytsel LJ, Brada M |
International Journal of Radiation Oncology Biology Physics |
1992 |
128 |
4.41 |
UK |
Clinical |
77 |
58 |
The high incidence of tumor dissemination in myxopapillary ependymoma in pediatric patients: report of five cases and review of the literature |
Fassett DR, Kestle JRW |
Journal of Neurosurgery |
2005 |
70 |
4.38 |
USA |
Clinical |
39 |
59 |
Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a children’s cancer group study |
Evans AE, Finlay JL |
Medical and Pediatric Oncology |
1996 |
106 |
4.24 |
USA |
Clinical |
45 |
60 |
Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood |
Needle MN, Phillips PC |
Cancer |
1997 |
97 |
4.04 |
USA |
Clinical |
34 |
61 |
Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma |
Metzger AK, Cogen PH |
Proceedings of The National Academy of Sciences of the United States of America |
1991 |
120 |
4 |
USA |
Clinical |
79 |
62 |
A multicenter study of the prognosis and treatment of adult brain ependymal tumors |
Reni M, Villa E |
Cancer |
2004 |
68 |
4 |
Italy |
Clinical |
19 |
63 |
Improved survival in cases of intracranial ependymoma after radiation-therapy: late report and recommendations |
Salazar OM, Aygun C |
Journal of Neurosurgery |
1983 |
150 |
3.95 |
USA |
Clinical |
81 |
64 |
Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma |
Wolfsberger S, Hainfellner J |
American Journal of Surgical Pathology |
2004 |
66 |
3.88 |
Austria |
Clinical |
37 |
65 |
Histologic prognostic factors in ependymoma |
Schiffer D, Tribolo A |
Childs Nervous System |
1991 |
116 |
3.87 |
Italy |
Clinical |
73 |
66 |
Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy |
van Veelen-Vincent, ML, Renier D |
Journal of Neurosurgery |
2002 |
72 |
3.79 |
Netherlands |
Clinical |
75 |
67 |
Influence of tumor grade on time to progression after irradiation for localized ependymoma in children |
Merchant TE, Kun LE |
International Journal of Radiation Oncology Biology Physics |
2002 |
71 |
3.74 |
USA |
Clinical |
76 |
68 |
Preliminary results from a phase II trial of conformal radiation therapy for pediatric patients with localized low-grade astrocytoma and ependymoma |
Merchant TE, Kun LE |
International Journal of Radiation Oncology Biology Physics |
2002 |
71 |
3.74 |
USA |
Clinical |
29 |
69 |
Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients |
Shaw EG, Earle JD |
International Journal of Radiation Oncology Biology Physics |
1987 |
126 |
3.71 |
USA |
Clinical |
90 |
70 |
Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study |
Massimino M, Madon E |
International Journal of Radiation Oncology Biology Physics |
2004 |
62 |
3.65 |
Italy |
Clinical |
52 |
71 |
Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy |
Merchant TE, Leibel SA |
Journal of Neurosurgery |
1997 |
85 |
3.54 |
USA |
Clinical |
56 |
72 |
Treatment of intracranial ependymoma by surgery alone |
Hukin J, Allen J |
Pediatric Neurosurgery |
1998 |
81 |
3.52 |
USA |
Clinical |
40 |
73 |
Postoperative radiotherapy in the management of spinal-cord ependymoma |
Whitaker SJ, Brada M |
Journal of Neurosurgery |
1991 |
105 |
3.5 |
UK |
Clinical |
24 |
74 |
Differential-diagnosis of chordoma, chondroid, and ependymal tumors as aided by anti-intermediate filament antibodies |
Miettinen M, Virtanen I |
American Journal of Pathology |
1983 |
129 |
3.39 |
Finland |
Clinical |
22 |
75 |
Symptomatic subependymoma: report of 21 cases with review of literature |
Scheithauer BW |
Journal of Neurosurgery |
1978 |
141 |
3.28 |
USA |
Clinical |
91 |
76 |
Postoperative radiotherapy for intracranial ependymoma: analysis of prognostic factors and patterns of failure |
Oya N, Hiraoka M |
Journal of Neuro-Oncology |
2002 |
62 |
3.26 |
Japan |
Clinical |
96 |
77 |
Astroblastoma: radiologic-pathologic correlation and distinction from ependymoma |
Port JD, Pomper MG |
American Journal of Neuroradiology |
2002 |
59 |
3.11 |
USA |
Clinical |
85 |
78 |
Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma |
Reardon DA, Look AT |
Genes Chromosomes & Cancer |
1999 |
65 |
2.95 |
USA |
Basic science |
97 |
79 |
Stereotactic radiosurgery for recurrent ependymoma |
Stafford SL, Schomberg PJ |
Cancer |
2000 |
59 |
2.81 |
USA |
Clinical |
98 |
80 |
Pediatric low-grade and ependymal spinal cord tumors |
Merchant TE, Kun LE |
Pediatric Neurosurgery |
2000 |
59 |
2.81 |
USA |
Clinical |
67 |
81 |
Intracranial ependymoma long-term outcome, patterns of failure |
Kovalic JJ, Roth KA |
Journal of Neuro-Oncology |
1993 |
78 |
2.79 |
USA |
Clinical |
41 |
82 |
Subcutaneous sacrococcygeal myxopapillary ependymoma: a clinicopathologic study of 32 cases |
Helwig EB, Stern JB |
American Journal of Clinical Pathology |
1984 |
102 |
2.76 |
USA |
Clinical |
93 |
83 |
Clinicopathologic study of 61 patients with ependymoma including mib-1 immunohistochemistry |
Prayson RA |
Annals of Diagnostic Pathology |
1999 |
60 |
2.73 |
USA |
Clinical |
60 |
84 |
Ependymoma: internal correlations among pathological signs: the anaplastic variant |
Schiffer D, Vigliani MC |
Neurosurgery |
1991 |
80 |
2.67 |
Italy |
Clinical |
62 |
85 |
The role of prophylactic spinal irradiation in localized intracranial ependymoma |
Vanuytsel L, Brada M |
International Journal of Radiation Oncology Biology Physics |
1991 |
79 |
2.63 |
UK |
Clinical |
94 |
86 |
Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma: a report of the children's cancer group |
Mason WP, Finlay JL |
Journal of Neuro-Oncology |
1998 |
60 |
2.61 |
USA |
Clinical |
53 |
87 |
Ependymal and choroid-plexus tumors: cytokeratin and GFAP expression |
Mannoji H, Becker LE |
Cancer |
1988 |
84 |
2.55 |
Canada |
Clinical |
68 |
88 |
Intracranial ependymoma and subependymoma: MR manifestations |
Spoto GP, Solomon M |
American Journal of Neuroradiology |
1990 |
78 |
2.52 |
USA |
Clinical |
72 |
89 |
Intracranial ependymoma in children: analysis of prognostic factors |
Chiu JK, Shallenberger R |
Journal of Neuro-Oncology |
1992 |
73 |
2.52 |
USA |
Clinical |
86 |
90 |
MR characteristics of histopathologic subtypes of spinal ependymoma |
Kahan H, Bruce JH |
American Journal of Neuroradiology |
1996 |
63 |
2.52 |
USA |
Clinical |
99 |
91 |
Tanycytic ependymoma |
Langford LA, Barre GM |
Ultrastructural Pathology |
1997 |
59 |
2.46 |
USA |
Clinical |
92 |
92 |
A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma: a phase-II study |
Grill J, Hartmann O |
Pediatric Neurosurgery |
1996 |
61 |
2.44 |
France |
Clinical |
43 |
93 |
Extra-spinal ependymomas: report of 3 cases |
Morantz RA, Masterson BJ |
Journal of Neurosurgery |
1979 |
99 |
2.36 |
USA |
Clinical |
20 |
94 |
A metastasizing ependymoma of the cauda equina |
Weiss, L |
Cancer |
1955 |
148 |
2.24 |
USA |
Clinical |
48 |
95 |
Delayed distant metastasis from a subcutaneous sacrococcygeal ependymoma: case report, with tissue-culture, ultrastructural observations and review of literature |
Wolff M, Duby MM |
Cancer |
1972 |
93 |
1.9 |
USA |
Review |
47 |
96 |
Secretory ependymoma of filum terminale |
Miller CA Torack RA |
Acta Neuropathologica |
1970 |
95 |
1.86 |
USA |
Clinical |
51 |
97 |
Is subependymoma (subependymal glomerate astrocytoma) an astrocytoma or ependymoma: comparative ultrastructural and tissue-culture study |
Fu YS, Young HF |
Cancer |
1974 |
86 |
1.83 |
USA |
Clinical |
87 |
98 |
Melanin as a component of cerebral gliomas: melanotic cerebral ependymoma |
Mccloskey JJ, Blacker HM |
Cancer |
1976 |
63 |
1.4 |
USA |
Clinical |
61 |
99 |
Ependymoma of the brain: pathologic aspects |
Svien HJ, Craig WM |
Neurology |
1953 |
80 |
1.18 |
USA |
Review |
71 |
100 |
A study of tumors arising from ependymal cells |
Bailey P |
Archives of Neurology And Psychiatry |
1924 |
75 |
0.77 |
USA |
Clinical |